Read the full press release here: #KidneyCancerAndRCCDrugsMarket #Oncology #CancerResearch #PharmaInnovation #DrugDevelopment #Immunotherapy #HealthcareStrategy #MarketInsights #RCCDrugs #GlobalHealth #Biopharma #MedTech #MarketExpansion #RenalCellCarcinoma #OncologyTrends #Pharmaceuticals #FutureOfHealthcare #DrugPipeline #MedicalInnovation #CancerTherapies #GlobalMarkets #Biotech #HealthTech #MarketForecast #MarkAndSparkSolutions To view or add a comment, sign in $ - % Genmabs move to acquire Dutch biotech Merus N.V
Common side effects include: Nausea Diarrhea Vomiting Stomach pain Constipation Headache More serious side effects might occur, though less commonly, such as pancreatitis, kidney problems, and possible thyroid tumors
Last week, Sun Pharma announced plans to introduce its generic semaglutide injection in the country, and now Novo Nordisk is set to launch Extensior, a lower-cost authorized copy of Ozempic (semaglutide), in South Africa on July 27, through a partnership with healthcare company Acino, in the same 0.25 mg, 0.5 mg, and 1 mg doses as Ozempic, and will be priced below the branded product
J.MichieS